KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Cash from Operations (2016 - 2025)

Amgen has reported Cash from Operations over the past 17 years, most recently at 1603000000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 1603000000.0 for Q4 2025, down 66.4% from a year ago — trailing twelve months through Dec 2025 was 9958000000.0 (down 13.33% YoY), and the annual figure for FY2025 was 9958000000.0, down 13.33%.
  • Cash from Operations for Q4 2025 was 1603000000.0 at Amgen, down from 4684000000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AMGN hit a ceiling of 4771000000.0 in Q4 2024 and a floor of 538000000.0 in Q4 2023.
  • Median Cash from Operations over the past 5 years was 2349000000.0 (2021), compared with a mean of 2445050000.0.
  • Biggest five-year swings in Cash from Operations: tumbled 79.69% in 2023 and later soared 786.8% in 2024.
  • Amgen's Cash from Operations stood at 2808000000.0 in 2021, then fell by 5.66% to 2649000000.0 in 2022, then tumbled by 79.69% to 538000000.0 in 2023, then soared by 786.8% to 4771000000.0 in 2024, then tumbled by 66.4% to 1603000000.0 in 2025.
  • The last three reported values for Cash from Operations were 1603000000.0 (Q4 2025), 4684000000.0 (Q3 2025), and 2280000000.0 (Q2 2025) per Business Quant data.